Lander’s letters highlighted that pharmacy giants risk both women’s health and investor interests by not dispensing mifepristone, underscoring a push for broader access in legal states.
State financial officers criticized Lander's actions as politicizing Costco’s business and stated decision-making should be left to the company's leadership rather than outside pressures.
The letter from state officials emphasized that these actions represent an inappropriate attempt to integrate political views into marketplace decisions, urging retailers to disregard external political pressures.
Lander argued that mifepristone's availability would not only benefit reproductive health but also enhance customer satisfaction and long-term shareholder value for the pharmacies.
Collection
[
|
...
]